Skip to main content

Neomycin topical Pregnancy and Breastfeeding Warnings

Brand names: Myciguent

Neomycin topical Pregnancy Warnings

The manufacturer makes no recommendation regarding use during pregnancy.

US FDA pregnancy category: Not formally assigned to a pregnancy category.

Animal studies have not been reported. There are no controlled data in human pregnancy.

See references

Neomycin topical Breastfeeding Warnings

The manufacturer makes no recommendation regarding use during lactation.

Excreted into human milk: Data not available
Excreted into animal milk: Data not available

Comments:
-The effects in the nursing infant are unknown; negligible risk is expected, however, topical application to the nipple may increase risk for diarrhea in the infant.
-Ointments should not be applied to the breast prior to breastfeeding; water miscible cream or gel products should be used if necessary.

See references

See also

References for pregnancy information

  1. (2001) "Product Information. Myciguent (neomycin topical)." Pharmacia and Upjohn
  2. Cerner Multum, Inc (2015) "Malaysia product information."

References for breastfeeding information

  1. (2001) "Product Information. Myciguent (neomycin topical)." Pharmacia and Upjohn
  2. United States National Library of Medicine (2013) Toxnet. Toxicology Data Network. http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT
  3. Cerner Multum, Inc (2015) "Malaysia product information."

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer